Sulphonylurea for type 2 diabetes
23 results
1 - 23
Sulphonylurea for type 2 diabetes 
Sulphonylurea monotherapy for patients with type 2 diabetes mellitus: Cochrane systematic review- Metformin and second‐ or third‐generation sulphonylurea combination therapy for adults with type 2 diabetes mellitus
- Comprehensive treatment and follow-up of type 2 diabetes
- Glucagon-like peptide analogues for type 2 diabetes mellitus: Cochrane systematic review
- Alpha-glucosidase inhibitors for type 2 diabetes mellitus: Cochrane systematic review
- Interventions for latent autoimmune diabetes (LADA) in adults: Cochrane systematic review
- Insulin secretagogues for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus
- Interventions for people with type 2 diabetes mellitus fasting during Ramadan
- Insulin monotherapy versus combinations of insulin with oral hypoglycaemic agents in patients with type 2 diabetes mellitus
- Metformin for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus
- Metformin monotherapy for adults with type 2 diabetes mellitus
- Insulin monotherapy compared with the addition of oral glucose‐lowering agents to insulin for people with type 2 diabetes already on insulin therapy and inadequate glycaemic control
- Conservative (non-surgical) treatment of obesity